Report Summary
The global Ophthalmol Drug market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Ophthalmol Drug market based on company, product type, end user and key regions.
This report studies the global market size of Ophthalmol Drug in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Ophthalmol Drug in these regions.
This research report categorizes the global Ophthalmol Drug market by top players/brands, region, type and end user. This report also studies the global Ophthalmol Drug market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Allergan
Roche
Valeant
Regeneron
Santen
Bayer
Pfizer
Senju
Akorn
Market size by Product
Retinal disorders drugs
Allergic, inflammatory and infective drugs
Glaucoma drugs
Dry eye drugs
Market size by End User
Glaucoma
Dry eye syndrome
Retinal diseases
Other ophthalmic indications
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Ophthalmol Drug market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Ophthalmol Drug market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Ophthalmol Drug companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Ophthalmol Drug submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Ophthalmol Drug are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Ophthalmol Drug market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Ophthalmol Drug Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Ophthalmol Drug Market Size Growth Rate by Product
1.4.2 Retinal disorders drugs
1.4.3 Allergic, inflammatory and infective drugs
1.4.4 Glaucoma drugs
1.4.5 Dry eye drugs
1.5 Market by End User
1.5.1 Global Ophthalmol Drug Market Size Growth Rate by End User
1.5.2 Glaucoma
1.5.3 Dry eye syndrome
1.5.4 Retinal diseases
1.5.5 Other ophthalmic indications
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Ophthalmol Drug Market Size
2.1.1 Global Ophthalmol Drug Revenue 2017-2027
2.1.2 Global Ophthalmol Drug Sales 2017-2027
2.2 Ophthalmol Drug Growth Rate by Regions
2.2.1 Global Ophthalmol Drug Sales by Regions
2.2.2 Global Ophthalmol Drug Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Ophthalmol Drug Sales by Manufacturers
3.1.1 Ophthalmol Drug Sales by Manufacturers
3.1.2 Ophthalmol Drug Sales Market Share by Manufacturers
3.1.3 Global Ophthalmol Drug Market Concentration Ratio (CR5 and HHI)
3.2 Ophthalmol Drug Revenue by Manufacturers
3.2.1 Ophthalmol Drug Revenue by Manufacturers (2017-2020)
3.2.2 Ophthalmol Drug Revenue Share by Manufacturers (2017-2020)
3.3 Ophthalmol Drug Price by Manufacturers
3.4 Ophthalmol Drug Manufacturing Base Distribution, Product Types
3.4.1 Ophthalmol Drug Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Ophthalmol Drug Product Type
3.4.3 Date of International Manufacturers Enter into Ophthalmol Drug Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Ophthalmol Drug Sales by Product
4.2 Global Ophthalmol Drug Revenue by Product
4.3 Ophthalmol Drug Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Ophthalmol Drug Breakdown Data by End User
6 North America
6.1 North America Ophthalmol Drug by Countries
6.1.1 North America Ophthalmol Drug Sales by Countries
6.1.2 North America Ophthalmol Drug Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Ophthalmol Drug by Product
6.3 North America Ophthalmol Drug by End User
7 Europe
7.1 Europe Ophthalmol Drug by Countries
7.1.1 Europe Ophthalmol Drug Sales by Countries
7.1.2 Europe Ophthalmol Drug Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Ophthalmol Drug by Product
7.3 Europe Ophthalmol Drug by End User
8 Asia Pacific
8.1 Asia Pacific Ophthalmol Drug by Countries
8.1.1 Asia Pacific Ophthalmol Drug Sales by Countries
8.1.2 Asia Pacific Ophthalmol Drug Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Ophthalmol Drug by Product
8.3 Asia Pacific Ophthalmol Drug by End User
9 Central & South America
9.1 Central & South America Ophthalmol Drug by Countries
9.1.1 Central & South America Ophthalmol Drug Sales by Countries
9.1.2 Central & South America Ophthalmol Drug Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Ophthalmol Drug by Product
9.3 Central & South America Ophthalmol Drug by End User
10 Middle East and Africa
10.1 Middle East and Africa Ophthalmol Drug by Countries
10.1.1 Middle East and Africa Ophthalmol Drug Sales by Countries
10.1.2 Middle East and Africa Ophthalmol Drug Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Ophthalmol Drug by Product
10.3 Middle East and Africa Ophthalmol Drug by End User
11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Novartis Ophthalmol Drug Products Offered
11.1.5 Novartis Recent Development
11.2 Allergan
11.2.1 Allergan Company Details
11.2.2 Company Business Overview
11.2.3 Allergan Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Allergan Ophthalmol Drug Products Offered
11.2.5 Allergan Recent Development
11.3 Roche
11.3.1 Roche Company Details
11.3.2 Company Business Overview
11.3.3 Roche Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.3.4 Roche Ophthalmol Drug Products Offered
11.3.5 Roche Recent Development
11.4 Valeant
11.4.1 Valeant Company Details
11.4.2 Company Business Overview
11.4.3 Valeant Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Valeant Ophthalmol Drug Products Offered
11.4.5 Valeant Recent Development
11.5 Regeneron
11.5.1 Regeneron Company Details
11.5.2 Company Business Overview
11.5.3 Regeneron Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Regeneron Ophthalmol Drug Products Offered
11.5.5 Regeneron Recent Development
11.6 Santen
11.6.1 Santen Company Details
11.6.2 Company Business Overview
11.6.3 Santen Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Santen Ophthalmol Drug Products Offered
11.6.5 Santen Recent Development
11.7 Bayer
11.7.1 Bayer Company Details
11.7.2 Company Business Overview
11.7.3 Bayer Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Bayer Ophthalmol Drug Products Offered
11.7.5 Bayer Recent Development
11.8 Pfizer
11.8.1 Pfizer Company Details
11.8.2 Company Business Overview
11.8.3 Pfizer Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Pfizer Ophthalmol Drug Products Offered
11.8.5 Pfizer Recent Development
11.9 Senju
11.9.1 Senju Company Details
11.9.2 Company Business Overview
11.9.3 Senju Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.9.4 Senju Ophthalmol Drug Products Offered
11.9.5 Senju Recent Development
11.10 Akorn
11.10.1 Akorn Company Details
11.10.2 Company Business Overview
11.10.3 Akorn Ophthalmol Drug Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Akorn Ophthalmol Drug Products Offered
11.10.5 Akorn Recent Development
12 Future Forecast
12.1 Ophthalmol Drug Market Forecast by Regions
12.1.1 Global Ophthalmol Drug Sales Forecast by Regions 2021-2027
12.1.2 Global Ophthalmol Drug Revenue Forecast by Regions 2021-2027
12.2 Ophthalmol Drug Market Forecast by Product
12.2.1 Global Ophthalmol Drug Sales Forecast by Product 2021-2027
12.2.2 Global Ophthalmol Drug Revenue Forecast by Product 2021-2027
12.3 Ophthalmol Drug Market Forecast by End User
12.4 North America Ophthalmol Drug Forecast
12.5 Europe Ophthalmol Drug Forecast
12.6 Asia Pacific Ophthalmol Drug Forecast
12.7 Central & South America Ophthalmol Drug Forecast
12.8 Middle East and Africa Ophthalmol Drug Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Ophthalmol Drug Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
